Investing Profile

Alain Huriez

InvestorVC
Venture Partner at Advent Life Sciences
Photo of Alain Huriez, Venture Partner at Advent Life Sciences

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Advent Life Sciences Venture Partner
$25K - $5.0M
$1M
7
CompanyStageDateRound SizeTotal Raised
Astraveus
SeedJun 2023$18M
$18M
Co-investors: Fiona MacLaughlin (Johnson & Johnson Innovation)
Anoat Therapeutics
SeedJun 2023$2M
$2M
ARTHEx Biotech
Series BMay 2023$46M
SeedJul 2020$5M
$51M
Co-investors: Jose Mesa (Alta Life Sciences)
Calida Therapeutics
SeedApr 2023$2M
$2M
Tridek-One
Series UnknownSep 2022$16M
$16M
Co-investors: Klaus Breiner (Pureos Bioventures)
Wellium
Series UnknownMar 2020$2M
$2M
Venture Partner Advent Life Sciences2022 - Present
Chairman & Managing Partner AdBio partners2015 - Present
President FONDATION ALBERT GLEIZES2006 - Present
Chairman of the Board Orphalan2015 - 2022
Honorary Chairman EPEMED2016 - 2021
Partner Advent Life Sciences2014 - 2021
Founder and Chairman EPEMED2009 - 2015
Chief Executive Officer TcLand (TcLand Expression & Effimune)2006 - 2012
Chief Executive Officer NEOVACS SA2003 - 2006
Associate Partner Truffle Capital2002 - 2003
Vice President Europe Biotechnology Quintiles1995 - 2002
International Project Manager - Project Director PSI CRO AG1991 - 1995
Physician- Head of Emergency Room CHU Amiens-Picardie1987 - 1991
University of Paris I: Panthéon-Sorbonne Master in Pharmaco Economics
Université de Picardie Jules Verne (Amiens) Doctor of Medicine - MD
Université de Picardie Jules Verne (Amiens) Master's degree